| Dr Radu Clifford Mihail, MD | |
|
1705 Warren Ave Ste 204-205, Williamsport, PA 17701-2647 | |
| (570) 320-7474 | |
| (570) 320-7479 |
| Full Name | Dr Radu Clifford Mihail |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology - Otolaryngology/facial Plastic Surgery |
| Location | 1705 Warren Ave Ste 204-205, Williamsport, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730186404 | NPI | - | NPPES |
| 02512105 | Medicaid | NY |
| Entity Name | Susquehanna Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346263266 PECOS PAC ID: 2264336460 Enrollment ID: O20040309000205 |
News Archive
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration for a new pediatric claim for its illumigene C. difficile molecular amplification test. C. difficile is a bacterium that is frequently associated with antibiotic therapy often causing diarrhea and, in severe cases, a life-threatening inflammation of the colon.
International child health experts to converge on London for Excellence in Paediatrics. Experts from all over the world will be converging on the Park Plaza Hotel in Westminster, London, from 2 - 4 December 2010 for Excellence in Paediatrics, which promises cutting edge topics by outstanding speakers.
Ferring Pharmaceuticals Inc. announced today the U.S. commercial availability of LYSTEDA™ (tranexamic acid) tablets, the only non-hormonal and non-surgical therapy indicated specifically for the treatment of women with cyclic heavy menstrual bleeding (HMB). In clinical studies, LYSTEDA significantly reduced menstrual blood loss (MBL) over three and six cycles of use with the reduction seen as early as the first cycle of use.
A new journal dedicated to sharing and discussion of informative clinical experiences is coming soon, with the launch of Anesthesia & Analgesia Case Reports, the newest publication of the International Anesthesia Research Society (IARS).
The enormous promise of regenerative medicine is matched by equally enormous challenges. But a new finding by a team of researchers led by Weill Cornell Medical College has the potential to improve both the safety and performance of reprogrammed cells.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Radu Clifford Mihail, MD 1201 Grampian Blvd, Williamsport, PA 17701-1900 Ph: () - | Dr Radu Clifford Mihail, MD 1705 Warren Ave Ste 204-205, Williamsport, PA 17701-2647 Ph: (570) 320-7474 |
News Archive
Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration for a new pediatric claim for its illumigene C. difficile molecular amplification test. C. difficile is a bacterium that is frequently associated with antibiotic therapy often causing diarrhea and, in severe cases, a life-threatening inflammation of the colon.
International child health experts to converge on London for Excellence in Paediatrics. Experts from all over the world will be converging on the Park Plaza Hotel in Westminster, London, from 2 - 4 December 2010 for Excellence in Paediatrics, which promises cutting edge topics by outstanding speakers.
Ferring Pharmaceuticals Inc. announced today the U.S. commercial availability of LYSTEDA™ (tranexamic acid) tablets, the only non-hormonal and non-surgical therapy indicated specifically for the treatment of women with cyclic heavy menstrual bleeding (HMB). In clinical studies, LYSTEDA significantly reduced menstrual blood loss (MBL) over three and six cycles of use with the reduction seen as early as the first cycle of use.
A new journal dedicated to sharing and discussion of informative clinical experiences is coming soon, with the launch of Anesthesia & Analgesia Case Reports, the newest publication of the International Anesthesia Research Society (IARS).
The enormous promise of regenerative medicine is matched by equally enormous challenges. But a new finding by a team of researchers led by Weill Cornell Medical College has the potential to improve both the safety and performance of reprogrammed cells.
› Verified 3 days ago
Kathryn Morton, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1705 Warren Ave Ste 204205, Suite 204205, Williamsport, PA 17701 Phone: 570-320-7474 | |
William Banks, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1705 Warren Ave Ste 204-205, Williamsport, PA 17701 Phone: 570-320-7474 | |
Dr. Phillip K. Pellitteri, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1705 Warren Ave Ste 204-205, Williamsport, PA 17701 Phone: 570-320-7474 Fax: 570-320-7479 |